Megaprosthesis in articular fractures of the lower limbs in fragile patients: a proposal for the therapeutic algorithm.

OBJECTIVE The use of megaprosthetic implants could provide substantial advantages in elderly population affected by complex fractures. The aim of the study was to identify the patients suitable to megaprosthetic implants in the treatment of lower limbs fractures, as well as periprosthetic fractures. PATIENTS AND METHODS From January 1st, 2015, to December 31st, 2021, all patients affected by femoral fractures with severe bone loss or previous surgery failure were retrospectively reviewed. ADL, IADL, SF-12 values pre- and post-operative were recorded. Hemoglobin value, NLR, PLR were recorded pre- and peri-operatively for all patients. Complications were recorded. All patients underwent a radiological follow-up. Significance was set at p ≤ 0.05. RESULTS 23 patients were considered eligible, 10 males and 13 females; the mean age was 72.87 years old (± 12.33), while the mean BMI was 27.2 points (± 5.2). The mean follow-up was 2 years (± 1.4). The mean preoperative ADL and IADL scores were correlated with a positive independence of the patient, while the mean postoperative scores corresponded to a moderate-low independence. Also the mean Mental and Physical SF12 scores saw a decrease in values. NLR values were higher in the first group of patients with complications. CONCLUSIONS A careful multiparametric and multidisciplinary patient selection is required to identify the suitable patient to this treatment.

[1]  U. Stöckle,et al.  Management of proximal femur fractures in the elderly: current concepts and treatment options , 2021, European Journal of Medical Research.

[2]  A. Ziranu,et al.  Euthyroid sick syndrome in hip fractures: Evaluation of postoperative anemia. , 2020, Injury.

[3]  G. Maccauro,et al.  Cemented versus cementless megaprosthesis in proximal femur metastatic disease: A systematic review , 2020, Orthopedic reviews.

[4]  T. Jennison,et al.  A case series of mortality and morbidity in distal femoral periprosthetic fractures. , 2020, Journal of orthopaedics.

[5]  A. Bianchi,et al.  Euthyroid sick syndrome in hip fractures: Valuation of vitamin D and parathyroid hormone axis. , 2020, Injury.

[6]  B. Springer,et al.  Acute Distal Femoral Replacement for Fractures About the Knee in the Elderly. , 2020, The Orthopedic clinics of North America.

[7]  J. Goulet,et al.  Modern Implant Options for the Treatment of Distal Femur Fractures. , 2019, The Journal of the American Academy of Orthopaedic Surgeons.

[8]  S. Rajasekaran,et al.  Megaprosthesis in distal femur nonunions in elderly patients—experience from twenty four cases , 2019, International Orthopaedics.

[9]  G. Onder,et al.  A 12-year retrospective analysis of differences between elderly and oldest old patients referred to the emergency department of a large tertiary hospital. , 2019, Maturitas.

[10]  L. Capasso,et al.  Secondary femur fracture following treatment with anterograde nailing: the state of the art. , 2018, Journal of biological regulators and homeostatic agents.

[11]  N. Maffulli,et al.  Single dose cefazolin is safe and effective for pre-operative prophylaxis in orthopaedic oncology. , 2018, Journal of biological regulators and homeostatic agents.

[12]  N. Veronese,et al.  Epidemiology and social costs of hip fracture. , 2018, Injury.

[13]  J. Argenson,et al.  Primary total knee arthroplasty for acute fracture around the knee. , 2017, Orthopaedics & traumatology, surgery & research : OTSR.

[14]  P. Giannoudis,et al.  A 3 year minimum follow up of Endoprosthetic replacement for distal femoral fractures - An alternative treatment option. , 2017, Journal of orthopaedics.

[15]  A. Piccioli,et al.  Infective complications in tumour endoprostheses implanted after pathological fracture of the limbs. , 2016, Injury.

[16]  G. Maccauro,et al.  Silver-Coated Hip Megaprosthesis in Oncological Limb Savage Surgery , 2016, BioMed research international.

[17]  R. Windhager,et al.  Megaprostheses in the treatment of periprosthetic fractures of the knee joint: indication, technique, results and review of literature , 2016, International Orthopaedics.

[18]  B. Moretti,et al.  Retrospective review of tibial plateau fractures treated by two methods without staging. , 2015, Injury.

[19]  D. Hak,et al.  Osteoporosis and the orthopaedic surgeon: basic concepts for successful co-management of patients’ bone health , 2014, International Orthopaedics.

[20]  G. Calori,et al.  Megaprosthesis in large bone defects: opportunity or chimaera? , 2014, Injury.

[21]  S. Hurwitz,et al.  Distal Femoral Fractures: Current Concepts , 2010, The Journal of the American Academy of Orthopaedic Surgeons.

[22]  Margaret A Dudeck,et al.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. , 2008, American journal of infection control.

[23]  I. McDowell,et al.  A global clinical measure of fitness and frailty in elderly people , 2005, Canadian Medical Association Journal.

[24]  D. Ammeen,et al.  Classification and preoperative radiographic evaluation: knee. , 1998, The Orthopedic clinics of North America.

[25]  W H Harris,et al.  Femoral component loosening using contemporary techniques of femoral cement fixation. , 1982, The Journal of bone and joint surgery. American volume.

[26]  F. De Maio,et al.  Induced membrane by silver-coated knee megaprosthesis: keep or toss? , 2020, Journal of biological regulators and homeostatic agents.

[27]  G. Maccauro,et al.  Innovations in prevention of infections in oncological megaprostheses: a narrative review. , 2019, Journal of biological regulators and homeostatic agents.

[28]  Mauricio Kfuri,et al.  Internal fixators: a safe option for managing distal femur fractures? , 2014, Acta ortopedica brasileira.

[29]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.